search
Back to results

Probiotics in Elderly Patients With Medical Conditions (Probiotics)

Primary Purpose

Aging, Constipation, Multi-Core Disease

Status
Completed
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
microbial cell preparation [MCP]
placebo
Sponsored by
Universiti Kebangsaan Malaysia Medical Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Aging focused on measuring microbial cell preparation, Hexbio®, probiotics, elderly, chronic medical conditions, constipation,

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

-clinical diagnosis of constipation

Exclusion Criteria:

  • Parkinson's disease,
  • spinal cord lesions
  • post radiation strictures
  • on calcium supplements of greater than 1,500 mg per day
  • immune-deficiency
  • critical illness

Sites / Locations

  • Universiti Kebangsaan Malaysia Medical Faculty

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Placebo

Hexbio® MCP

Arm Description

placebo were manufactured and supplied by B-Crobes Laboratory Sdn. Bhd. as powder in identical sachets with active comparator and labelled as A

The treatment sample is labelled as B.This is an orange-flavoured, granulated microbial cell preparation containing 30 billion colony forming units (cfu) of Lactobacilli and Bifidobacteria strains: Lactobacillus acidophilus BCMC® 12130, Lactobacillus casei BCMC® 12313, Lactobacillus lactis BCMC® 12451, Bifidobacterium bifidum BCMC® 02290, Bifidobacterium infantis BCMC®02129, Bifidobacterium longum BCMC® 02120. The placebo sample was similar in appearance and taste, but contained no microbial cells.

Outcomes

Primary Outcome Measures

changes in stool output frequency
numerical scale 0-100 used, 0= nil (worst), 100= good, medium score was used for data interpratation
changes in stool consistency
The Bristol Stool scale was used, scale type 1 to 7, type 1 = hard stool and type 7=entirely liquid stool, medium score was used for data intepretation

Secondary Outcome Measures

patients' perceptions of an improvement in their constipation-related symptoms 1
straining: likert score of 0 to 10 was used, 0=no straining, 10= worst straining
patients' perceptions of an improvement in their constipation-related symptoms 2
sensation of incomplete evacuation: likert score of 0 to 10 was used, 0= total incomplete evacuation, 10=complete evacuation
patients' perceptions of an improvement in their constipation-related symptoms 3
sensation of ano-rectal obstruction/blockage: likert score of 0 to 10 was used, 0=complete obstruction, 10= complete relieved
patients' perceptions of an improvement in their constipation-related symptoms 4
Need of manual evacuation to aid defeacation: likert score of 0 to 10 was used, 0=no evacuation needed, 10=total evacuation needed

Full Information

First Posted
July 17, 2019
Last Updated
July 24, 2019
Sponsor
Universiti Kebangsaan Malaysia Medical Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT04035616
Brief Title
Probiotics in Elderly Patients With Medical Conditions
Acronym
Probiotics
Official Title
Evaluation of the Efficacy of Probiotics in Treating Constipation in Elderly Patients With Multiple Chronic Co-morbidities: a Randomized Control Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
September 1, 2018 (Actual)
Primary Completion Date
December 31, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universiti Kebangsaan Malaysia Medical Centre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Study of efficacy of probiotic in older patients with multiple co-morbidites and constipation
Detailed Description
Background and aims: Probiotics are known to have a beneficial effect on the management of constipation. Thus, the current study objective was to evaluate the impact of a microbial cell preparation (MCP) (Hexbio®; comprising Bifidobacterium and Lactobacillus strains) on stool frequency, consistency, and constipation-related symptoms in elderly patients with multiple chronic medical conditions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aging, Constipation, Multi-Core Disease
Keywords
microbial cell preparation, Hexbio®, probiotics, elderly, chronic medical conditions, constipation,

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The subjects received either the probiotics or a placebo.
Masking
ParticipantInvestigator
Masking Description
Both investigators and patients were unaware of the assignment and were blinded to the labelling process performed by the sample supplier. The patients were randomly allocated to one of two groups; those who received sample labelled A or B. Emergency code break were kept at the manufacturing factory and no code break was needed throughout the trial duration. Both the MCP and placebo were manufactured and supplied by B-Crobes Laboratory Sdn. Bhd. as powder in identical sachets and labelled as A and B. Investigators have no contact with the manufacturing staffs at any point during the trial process. Following data analysis, unblinding was performed to complete the study process.
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
placebo were manufactured and supplied by B-Crobes Laboratory Sdn. Bhd. as powder in identical sachets with active comparator and labelled as A
Arm Title
Hexbio® MCP
Arm Type
Active Comparator
Arm Description
The treatment sample is labelled as B.This is an orange-flavoured, granulated microbial cell preparation containing 30 billion colony forming units (cfu) of Lactobacilli and Bifidobacteria strains: Lactobacillus acidophilus BCMC® 12130, Lactobacillus casei BCMC® 12313, Lactobacillus lactis BCMC® 12451, Bifidobacterium bifidum BCMC® 02290, Bifidobacterium infantis BCMC®02129, Bifidobacterium longum BCMC® 02120. The placebo sample was similar in appearance and taste, but contained no microbial cells.
Intervention Type
Dietary Supplement
Intervention Name(s)
microbial cell preparation [MCP]
Other Intervention Name(s)
Hexbio®
Intervention Description
active microbial cell preparation
Intervention Type
Other
Intervention Name(s)
placebo
Intervention Description
inactive ingredient
Primary Outcome Measure Information:
Title
changes in stool output frequency
Description
numerical scale 0-100 used, 0= nil (worst), 100= good, medium score was used for data interpratation
Time Frame
7 days
Title
changes in stool consistency
Description
The Bristol Stool scale was used, scale type 1 to 7, type 1 = hard stool and type 7=entirely liquid stool, medium score was used for data intepretation
Time Frame
7 days
Secondary Outcome Measure Information:
Title
patients' perceptions of an improvement in their constipation-related symptoms 1
Description
straining: likert score of 0 to 10 was used, 0=no straining, 10= worst straining
Time Frame
7 days
Title
patients' perceptions of an improvement in their constipation-related symptoms 2
Description
sensation of incomplete evacuation: likert score of 0 to 10 was used, 0= total incomplete evacuation, 10=complete evacuation
Time Frame
7 days
Title
patients' perceptions of an improvement in their constipation-related symptoms 3
Description
sensation of ano-rectal obstruction/blockage: likert score of 0 to 10 was used, 0=complete obstruction, 10= complete relieved
Time Frame
7 days
Title
patients' perceptions of an improvement in their constipation-related symptoms 4
Description
Need of manual evacuation to aid defeacation: likert score of 0 to 10 was used, 0=no evacuation needed, 10=total evacuation needed
Time Frame
7 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: -clinical diagnosis of constipation Exclusion Criteria: Parkinson's disease, spinal cord lesions post radiation strictures on calcium supplements of greater than 1,500 mg per day immune-deficiency critical illness
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
hayati Yaakup, MBBS
Organizational Affiliation
National University of Malaysia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universiti Kebangsaan Malaysia Medical Faculty
City
Kuala lumpur
State/Province
Wilayah Persekutuan Kuala Lumpur
ZIP/Postal Code
56000
Country
Malaysia

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33244562
Citation
Ghafar MYA, Yaakup H, Ali RAR, Shah SA. Evaluation of the Efficacy of Probiotics (MCP(R) BCMC(R) Strains) Treating Constipation in Elderly Patients with Multiple Chronic Co-Morbidities: A Randomized Control Trial. J Nutr Health Aging. 2020;24(10):1066-1072. doi: 10.1007/s12603-020-1494-1.
Results Reference
derived

Learn more about this trial

Probiotics in Elderly Patients With Medical Conditions

We'll reach out to this number within 24 hrs